The Clinical Research Conference was held for a fourth consecutive year with the participation of leading companies from the pharmaceutical industry, government and state officials, representatives from the field of healthcare and leading international speakers from the European CRO Federation (EUCROF). The Conference was jointly organized by Ethos Events, Pharma & Health Business magazine on health and drug policy, and virus.com.gr portal, and took place on Tuesday 1st December 2015 at the Ethniki Asfalistiki Conference Centre.

The Conference concluded that despite the important advances that have been accomplished at institutional level, Greece still lags behind in clinical research due to major bureaucratic obstacles and distortions; due to these, only 2,000 clinical trials are currently being conducted in Greece, although according to international experience there is the potential for five times this number, which could attract investments worth 2 billion Euros to the country.

The aim of the 4th Clinical Research Conference was to highlight all aspects regarding the development of clinical research in the country. The ultimate goal was to analyse the existing distortions and to identify effective solutions to form the basis of a complete Operational Plan for promoting clinical research that will benefit both patients and the national economy.

The first part of the conference included speeches and three round tables which described clinical studies; the second part, entitled “HACRO SYMPOSIUM: New advances/services in CRO Business” involved the participation of expert international speakers on clinical research from the European CRO Federation (EUCROF) within the context of their annual General Assembly.

The conference was held courtesy of the Hellenic Association of Pharmaceutical Companies (SFEE), the Pan-Hellenic Union of Pharmaceutical Industries and HACRO

More than 300 attendees participated in the speeches and discussions, and over 1000 participants attended the conference through live-streaming services.